| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |